3 Reasons AIZ is Risky and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AIZ Cover Image

Assurant’s 16.3% return over the past six months has outpaced the S&P 500 by 7%, and its stock price has climbed to $276.84 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Is now the time to buy Assurant, or should you be careful about including it in your portfolio? Get the full stock story straight from our expert analysts, it’s free.

Why Is Assurant Not Exciting?

We’re happy investors have made money, but we’re sitting this one out for now. Here are three reasons we avoid AIZ, plus one stock we’d rather own.

1. Net Premiums Earned Point to Soft Demand

When insurers sell policies, they protect themselves from extremely large losses or an outsized accumulation of losses with reinsurance (insurance for insurance companies). Net premiums earned are therefore gross premiums less what’s ceded to reinsurers as a risk mitigation and transfer strategy.

Assurant’s net premiums earned has grown at a 5.2% annualized rate over the last five years, worse than the broader insurance industry and slower than its total revenue.

Assurant Trailing 12-Month Net Premiums Earned

2. Recent EPS Growth Below Our Standards

Although long-term earnings trends give us the big picture, we like to analyze EPS over a shorter period to see if we are missing a change in the business.

Assurant’s EPS grew at an unimpressive 13% compounded annual growth rate over the last two years. On the bright side, this performance was higher than its 7.6% annualized revenue growth and tells us the company became more profitable on a per-share basis as it expanded.

Assurant Trailing 12-Month EPS (Non-GAAP)

3. Substandard BVPS Growth Indicates Limited Asset Expansion

Book value per share (BVPS) serves as a key indicator of an insurer’s financial stability, reflecting a company’s ability to maintain adequate capital levels and meet its long-term obligations to policyholders.

To the detriment of investors, Assurant’s BVPS grew at a mediocre 11.8% annual clip over the last two years.

Assurant Quarterly Book Value per Share

Final Judgment

Assurant isn’t a terrible business, but it doesn’t pass our bar. With its shares topping the market in recent months, the stock trades at 2.2× forward P/B (or $276.84 per share). Investors with a higher risk tolerance might like the company, but we don’t really see a big opportunity at the moment. We’re pretty confident there are more exciting stocks to buy at the moment. We’d suggest looking at a dominant aerospace business that has perfected its M&A strategy.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.80
-2.51 (-1.01%)
AAPL  313.70
-3.61 (-1.14%)
AMD  548.75
+14.36 (2.69%)
BAC  60.67
+1.17 (1.97%)
GOOG  351.83
+1.16 (0.33%)
META  657.98
+1.25 (0.19%)
MSFT  383.39
-7.60 (-1.94%)
NVDA  204.93
+1.40 (0.69%)
ORCL  128.80
-2.74 (-2.08%)
TSLA  397.62
+2.86 (0.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.